CONCLUSIONS: In the PRIME-MR registry, 20% of patients with primary mitral regurgitation had severe TR at baseline. TR severity improved in 30% of TR≥Sev patients after successful M-TEER. The presence of TR≥Sev was independently associated with increased all-cause mortality at[…]
Read more...CONCLUSIONS: Failed-BEV and failed-SEV showed distinct failure mechanisms and timing of reintervention, but initial valve type did not impact reintervention strategy or survival after redo-TAVR or TAVR-explant.
Read more...CONCLUSION: More than half of VA-ECMO patients received a concurrent device, with increasing microaxial flow pump and declining IABP use. Complications and mortality differed across strategies and shock etiologies.
Read more...CONCLUSIONS: Interventional cardiologists could not reliably identify culprit arteries using coronary angiography in women with MINOCA, even after ECG and transthoracic echocardiography review. Our findings suggest that invasive angiography alone should not guide vessel selection for intracoronary imaging and support[…]
Read more...CONCLUSIONS: The extent of extravalvular CD correlates with AS severity and is associated with poor clinical outcomes across all AS stages. Further research is warranted to determine whether assessing CD should be integrated in the management of patients with AS.
Read more...CONCLUSIONS: These data suggest that the use of novel x-ray acquisition algorithms can improve image quality while maintaining or lowering radiation or iodine dose. The prospective evaluation of these algorithms within routine clinical practice is warranted in future clinical studies.
Read more...CONCLUSION: This proof-of-concept study demonstrates the feasibility of using AI to analyse CW Doppler spectra for rapid, non-invasive identification of reduced LVEF without requiring dedicated two-dimensional left ventricular imaging or ECG-gated volumetric analysis for model inference. By leveraging underutilized echocardiographic[…]
Read more...More than 10 million coronary angiograms are performed globally each year, providing a gold standard for detecting obstructive coronary artery disease. Yet, no obstructive lesions are identified in 70% of patients evaluated for ischemic heart disease. Up to half of[…]
Read more...Stent underexpansion remains a major contributor to restenosis and stent thrombosis following percutaneous coronary intervention (PCI), yet intravascular imaging is not used routinely in many settings. Digital stent enhancement (DSE) offers an angiography-based approach to improve visualization of metallic stents[…]
Read more...Myasthenia gravis (MG) is an autoimmune neuromuscular disorder primarily caused by autoantibodies against acetylcholine receptors (AChR), leading to muscle weakness. In 2021, efgartigimod was FDA-approved as the first neonatal Fc receptor (FcRn) blocker for generalized MG, reducing pathogenic IgG autoantibodies[…]
Read more...
1700 Broadway, 9th Floor
New York, NY 10019
646.434.4500
Please e-mail us if you would
like more information:
info@crf.org
© 2026, Cardiovascular Research Foundation®. All rights reserved.
